Watch VideoA new study found patients hospitalized in the New York metro area did not benefit from being prescribed the anti-malaria drug hydroxychloroquine.
That's the medicine President Donald Trump has repeatedly touted as a possible treatment for the coronavirus. The FDA also issued an emergency use authorization in late...
Study Shows COVID-19 Patients Did Not Benefit From Hydroxycholoroquine
Newsy
0 shares
1 views